Results of Round 5

Results of Round 5 National Blood Sector Research and Development Program

Applications to Round 5 of the National Blood Sector Research and Development Program closed on 28 September 2020 [with grants awarded in early 2021]. The NBA thanks all applicants who submitted an application to this round and is grateful to have received high quality input from clinical, research and government experts who participated in the review process and assisted the NBA in determining the mix of projects to be funded within the limited program budget.  The NBA is confident that the research funded through this round will provide significant contributions to the development of new knowledge in the blood sector. Congratulations to the grant awardees. Successful applications are listed below:

Patient Blood Management Project Grants

Principal Chief Investigator

Administering Institution

Amount (incl. GST)

Project Title
Prof Paul Monagle Murdoch Children’s Research Institute $485,974.00 Towards personalised blood product therapy after cardiopulmonary bypass in neonates and infants

A/Prof David Roxby

Flinders University

$104,956.43

Anaemia and transfusion prevalence in Indigenous and non-Indigenous intensive care, pregnant and cardiac patients

A/Prof Zoe McQuilten

Monash University

$170,616.56

International Point Prevalence Study of Intensive Care Unit Transfusion Practices – the InPUT study

Patient Blood Management Seed Grant

Principal Chief Investigator

Administering Institution

Amount (incl. GST)

Project Title

Prof Biswadev Mitra

Monash University

$54,969.00

Prehospital plasma for trauma

Immunoglobulin Project Grants

Principal Chief Investigator

Administering Institution

Amount (incl. GST)

Project Title

Dr Celina Jin

Melbourne Health

$163,460.00

Evaluating vaccine responses in specific antibody deficient patients receiving immunoglobulin treatment

A/Prof Stephen Reddel

ANZAC Health and Medical Research Foundation

$453,238.59

OPTIC trial: Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in CIDP (Chronic Inflammatory Demyelinating Polyneuropathy

Immunoglobulin Seed Grant

Principal Chief Investigator Administering Institution Amount (incl. GST) Project Title
Dr Jovanka King The University of Adelaide $55,000.00 A new blood test to guide immunoglobulin replacement therapy in patients with immunodeficiency diseases